With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.301224-40-8,(1,3-Dimesitylimidazolidin-2-ylidene)(2-isopropoxybenzylidene)ruthenium(VI) chloride,as a common compound, the synthetic route is as follows.
General procedure: In a glove box, a flask was charged with Ru complex 4 or 5 and Ag salt 3. Anhydrous degassed CH2Cl2 was then added and the resulting mixture was stirred at room temperature for 3h in the dark. The solids were filtered off through a Celite layer and washed with anhydrous (2mL). The solution was diluted with anhydrous hexane (10mL) and remaining precipitated Ag salt was again filtered off. Evaporation of the solvents on a rotary vacuum evaporator (40C, 1h, 25kPa) and finally at oil pump vacuum (25C, 1h, 1kPa) gave the products 1 or 2.
As the paragraph descriping shows that 301224-40-8 is playing an increasingly important role.
Reference£º
Article; Lipovska, Pavlina; Rathouska, Lucie; ?im?nek, Ond?ej; Ho?ek, Jan; Kola?ikova, Viola; Ryba?kova, Marketa; Cva?ka, Josef; Svoboda, Martin; Kvi?ala, Jaroslav; Journal of Fluorine Chemistry; vol. 191; (2016); p. 14 – 22;,
Highly efficient and robust molecular ruthenium catalysts for water oxidation
Catalysts | Special Issue : Ruthenium Catalysts – MDPI